Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Epi-progoitrin
2. Epiprogoitrin
3. Progoitrin, (s)-isomer
4. Progoitrin, Monopotassium Salt
1. Glucorapiferin
2. 585-95-5
3. 2(r)-hydroxy-3-butenyl Glucosinolate
4. S27t66w417
5. [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3r)-3-hydroxy-n-sulfooxypent-4-enimidothioate
6. 2(r)-2-hydroxy-3-butenyl Glucosinolate
7. Unii-s27t66w417
8. (r)-progoitrin
9. Chebi:79352
10. Dtxsid20974057
11. C08425
12. Q27288480
13. 1-s-[3-hydroxy-n-(sulfooxy)pent-4-enimidoyl]-1-thiohexopyranose
14. .beta.-d-glucopyranose, 1-thio-, 1-((3r)-3-hydroxy-n-(sulfooxy)-4-pentenimidate)
15. 1-s-[(3r)-3-hydroxy-n-(sulfooxy)pent-4-enimidoyl]-1-thio-beta-d-glucopyranose
16. Beta-d-glucopyranose, 1-thio-, 1-((3r)-3-hydroxy-n-(sulfooxy)-4-pentenimidate
17. Beta-d-glucopyranose, 1-thio-, 1-(3-hydroxy-n-(sulfooxy)-4-pentenimidate), (r)-
18. [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] (3r)-3-hydroxy-n-sulfooxy-pent-4-enimidothioate
19. Glucopyranose, 1-thio-, 1-((r)-3-hydroxy-4-pentenohydroximate) No-(hydrogen Sulfate), Beta-d-
| Molecular Weight | 389.4 g/mol |
|---|---|
| Molecular Formula | C11H19NO10S2 |
| XLogP3 | -1.9 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 389.04503815 g/mol |
| Monoisotopic Mass | 389.04503815 g/mol |
| Topological Polar Surface Area | 220 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 548 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 1 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
43
PharmaCompass offers a list of Glucorapiferin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Glucorapiferin manufacturer or Glucorapiferin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Glucorapiferin manufacturer or Glucorapiferin supplier.
PharmaCompass also assists you with knowing the Glucorapiferin API Price utilized in the formulation of products. Glucorapiferin API Price is not always fixed or binding as the Glucorapiferin Price is obtained through a variety of data sources. The Glucorapiferin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Glucorapiferin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glucorapiferin, including repackagers and relabelers. The FDA regulates Glucorapiferin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glucorapiferin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Glucorapiferin supplier is an individual or a company that provides Glucorapiferin active pharmaceutical ingredient (API) or Glucorapiferin finished formulations upon request. The Glucorapiferin suppliers may include Glucorapiferin API manufacturers, exporters, distributors and traders.
Glucorapiferin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glucorapiferin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Glucorapiferin GMP manufacturer or Glucorapiferin GMP API supplier for your needs.
A Glucorapiferin CoA (Certificate of Analysis) is a formal document that attests to Glucorapiferin's compliance with Glucorapiferin specifications and serves as a tool for batch-level quality control.
Glucorapiferin CoA mostly includes findings from lab analyses of a specific batch. For each Glucorapiferin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glucorapiferin may be tested according to a variety of international standards, such as European Pharmacopoeia (Glucorapiferin EP), Glucorapiferin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glucorapiferin USP).
